Cetirizine Hydrochloride
NDC 10135-762, Cetirizine Hydrochloride, tablet, from Marlex Pharmaceuticals, Inc.
- Product NDC
- 10135-762
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077498
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-762 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-762-01 | 10135076201 | 100 TABLET in 1 BOTTLE (10135-762-01) |
| 10135-762-03 | 10135076203 | 300 TABLET in 1 BOTTLE (10135-762-03) |
| 10135-762-05 | 10135076205 | 500 TABLET in 1 BOTTLE (10135-762-05) |
| 10135-762-30 | 10135076230 | 30 TABLET in 1 BOTTLE (10135-762-30) |
| 10135-762-90 | 10135076290 | 90 TABLET in 1 BOTTLE (10135-762-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10135-762 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-762 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-762. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.